Literature DB >> 11020144

Utility of the MMPI-2 in assessing gender dysphoric patients.

P P Miach1, E F Berah, J N Butcher, S Rouse.   

Abstract

We compared MMPI-2 (Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 1989) profiles of 2 groups of adult biological men requesting sex reassignment surgery; 1 group was diagnosed with Diagnostic and Statistical Manual of Mental Disorders (3rd ed., rev. [DSM-III-R]; American Psychiatric Association, 1987) transsexualism and the other with gender identity disorder of adolescence and adulthood, nontranssexual type (GIDAANT). Although the mean profiles for the transsexual group did not demonstrate any psychopathology, the GIDAANT group showed moderate psychopathology. A cluster analysis indicated that 85% of the transsexual group showed low psychopathology and 47% of the GIDAANT group showed severe psychopathology. Neither the MMPI-2 results nor the DSM-III-R clinical evaluation support the conclusion of many authors that transsexualism is associated with severe personality disorder; rather, the data indicate that transsexualism and other gender identity disorders without persistent wish for sex reassignment differ significantly in degree of psychopathology.

Entities:  

Mesh:

Year:  2000        PMID: 11020144     DOI: 10.1207/S15327752JPA7502_7

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  3 in total

1.  Personality disorders in persons with gender identity disorder.

Authors:  Dragana Duišin; Borjanka Batinić; Jasmina Barišić; Miroslav L Djordjevic; Svetlana Vujović; Marta Bizic
Journal:  ScientificWorldJournal       Date:  2014-05-13

2.  Efficacy of hormonal and mental treatments with MMPI in FtM individuals: cross-sectional and longitudinal studies.

Authors:  Hiroyuki Oda; Toshihiko Kinoshita
Journal:  BMC Psychiatry       Date:  2017-07-17       Impact factor: 3.630

3.  MMPI-2 Profile of French Transsexuals: The Role of Sociodemographic and Clinical Factors. A cross-sectional design.

Authors:  Mireille Bonierbale; Karine Baumstarck; Aurélie Maquigneau; Audrey Gorin-Lazard; Laurent Boyer; Anderson Loundou; Pascal Auquier; Christophe Lançon
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.